Science
Mechanism of Action
This extract functions by activating the skin's internal recycling system—autophagy—via the modulation of the AMPK/mTOR pathway and the LRSAM1 regulator. It significantly downregulates senescence markers like p53 and p21 while simultaneously inhibiting the JAK-STAT and NF-κB pathways to suppress pro-inflammatory chemokines such as CCL17 and CCL22.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Demonstrated significant inhibition of senescence-associated β-galactosidase and suppressed expression of p53, p21, and caveolin-1 in human dermal fibroblasts.
- 02 Topical application in vivo showed a marked reduction in dermatitis scores, epidermal thickening, and plasma levels of histamine and IgE.
Transparency
Dusting Analysis
Due to its complex extraction process and potent biological activity at the cellular level, this ingredient is frequently included in trace amounts for marketing purposes rather than at the therapeutic levels required to trigger autophagic flux.
The Formula
Formulation
Stability
Typically prepared in ethanol-water mixtures; stable in standard emulsion formats, though specific pH stability ranges have not been publicly established.
Synergies
- Niacinamide
- Ceramides
- Peptides
Safety
Safety Profile
While oral ingestion of related species (C. yanhusuo) is cautioned during pregnancy due to berberine content, no such contraindications exist for the topical application of C. heterocarpa extract.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-potential bioactive for precision skincare targeting cellular senescence and chronic inflammation.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources